Cribstone Capital Management’s GSK GSK Stock Holding History

Cribstone Capital Management’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-112	Closed	-$3K	–	438
2022 Q3	$3K	Hold	112	–	–	﹤0.01%	325
2022 Q2	$6K	Hold	112	–	–	﹤0.01%	291
2022 Q1	$6K	Sell	112 -10	-8%	-$543	﹤0.01%	305
2021 Q4	$7K	Hold	122	–	–	﹤0.01%	291
2021 Q3	$6K	Hold	122	–	–	﹤0.01%	286
2021 Q2	$6K	Hold	122	–	–	﹤0.01%	294
2021 Q1	$5K	Hold	122	–	–	﹤0.01%	282
2020 Q4	$6K	Hold	122	–	–	﹤0.01%	272
2020 Q3	$6K	Sell	122 -112	-48%	-$5.61K	﹤0.01%	229
2020 Q2	$12K	Hold	234	–	–	0.01%	204
2020 Q1	$11K	Hold	234	–	–	0.01%	202
2019 Q4	$14K	Sell	234 -337	-59%	-$18.7K	0.01%	238
2019 Q3	$30K	Sell	571 -200	-26%	-$10.3K	0.02%	280
2019 Q2	$39K	Sell	771 -80	-9%	-$4.01K	0.02%	267
2019 Q1	$44K	Sell	851 -3,167	-79%	-$158K	0.02%	258
2018 Q4	$192K	Hold	4,018	–	–	0.1%	119
2018 Q3	$202K	Hold	4,018	–	–	0.09%	121
2018 Q2	$202K	Hold	4,018	–	–	0.1%	118
2018 Q1	$196K	Buy	4,018 +3,176	+377%	+$148K	0.1%	119
2017 Q4	$38K	Sell	842 -800	-49%	-$37K	0.02%	346
2017 Q3	$84K	Hold	1,642	–	–	0.04%	191
2017 Q2	$89K	Sell	1,642 -392	-19%	-$20.9K	0.05%	199
2017 Q1	$105K	Hold	2,034	–	–	0.06%	189
2016 Q4	$98K	Sell	2,034 -120	-6%	-$5.93K	0.06%	178
2016 Q3	$114K	Hold	2,154	–	–	0.07%	159
2016 Q2	$117K	Buy	+2,154	New	+$113K	0.07%	156

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

JEST

JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

AWA

Arete Wealth Advisors Chicago, Illinois $1.33B AUM 25.12% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return

Cribstone Capital Management's GSK Position: Q4 2022 in Review

Cribstone Capital Management sold out of GSK (GSK) in Q4 2022, closing a stake of 112 shares — an estimated $3K sold.

Cribstone Capital Management first reported a position in GSK in Q2 2016 and held it in 26 quarters. The position peaked at $202K in Q3 2018. 813 funds tracked by Wall St. Rank hold GSK as of Q4 2022.

Cribstone Capital Management reported no remaining GSK position as of Q4 2022 after selling out during the quarter.
Cribstone Capital Management sold 112 GSK shares in Q4 2022, an estimated $3K.
Cribstone Capital Management first reported a position in GSK in Q2 2016 and held it in 26 quarters.
Cribstone Capital Management's GSK position peaked at $202K in Q3 2018.
813 funds tracked by Wall St. Rank held GSK as of Q4 2022.

Based on Cribstone Capital Management's 13F filing for Q4 2022, filed 14 Feb 2023.